ARCHIVES

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

NCAB Committee Submits Drafts Of QRA Policy Statement

July 8, 1983

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

Health Policy: Organ Procurement Should Cover Wider Areas, IOM Report Says

August 6, 1999